Chemoradiotherapy screening in a novel biomimetic polymer based pancreatic cancer model-Reference-Cited by-同舟云学术

Chemoradiotherapy screening in a novel biomimetic polymer based pancreatic cancer model

Published:2019 Issue:71 Volume:9 Page:41649-41663
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Gupta Priyanka¹²³⁴⁵,Totti Stella¹²³⁴⁵,Pérez-Mancera Pedro A.⁶⁷⁸⁵,Dyke Eleanor⁹¹⁰¹¹⁴⁵,Nisbet Andrew⁹¹⁰¹¹⁴⁵,Schettino Giuseppe¹²³¹³⁵¹⁴,Webb Roger¹⁵³⁴⁵,Velliou Eirini G.¹²³⁴⁵^ORCID

Affiliation:

1. Bioprocess and Biochemical Engineering Group (BioProChem)

2. Department of Chemical and Process Engineering

3. University of Surrey

4. Guildford

5. UK

6. Department of Molecular and Clinical Cancer Medicine

7. University of Liverpool

8. Liverpool

9. Department of Medical Physics

10. The Royal Surrey County Hospital

11. NHS Foundation Trust

12. Department of Physics

13. Guildford GU2 7XH

14. Medical Radiation Science Group

15. The Ion Beam Centre

Abstract

Poly-urethane scaffold based 3D pancreatic cancer model enables realistic long term chemotherapy and radiotherapy screening. This model can be used for personalised treatment screening.

Funder

University of Surrey

Engineering and Physical Sciences Research Council

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2019/RA/C9RA09123H

Reference106 articles.

1. American Cancer Society , Cancer Facts & Figures 2018 , Atlanta , 2018

2. Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy